US Bancorp’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-454
| Closed | -$5.98K | – | 4307 |
|
|
2024
Q4 | $5.98K | Sell |
454
-110
| -20% | -$1.45K | ﹤0.01% | 3592 |
|
|
2024
Q3 | $6.32K | Sell |
564
-379
| -40% | -$4.25K | ﹤0.01% | 3497 |
|
|
2024
Q2 | $10.1K | Sell |
943
-761
| -45% | -$8.18K | ﹤0.01% | 3289 |
|
|
2024
Q1 | $25.4K | Buy |
1,704
+825
| +94% | +$12.3K | ﹤0.01% | 2994 |
|
|
2023
Q4 | $15.9K | Sell |
879
-159
| -15% | -$2.88K | ﹤0.01% | 3139 |
|
|
2023
Q3 | $18K | Sell |
1,038
-1,112
| -52% | -$19.3K | ﹤0.01% | 2929 |
|
|
2023
Q2 | $39K | Buy |
2,150
+1,270
| +144% | +$23K | ﹤0.01% | 2600 |
|
|
2023
Q1 | $23.4K | Buy |
880
+21
| +2% | +$559 | ﹤0.01% | 2901 |
|
|
2022
Q4 | $16.6K | Hold |
859
| – | – | ﹤0.01% | 3073 |
|
|
2022
Q3 | $18K | Buy |
859
+409
| +91% | +$8.57K | ﹤0.01% | 3061 |
|
|
2022
Q2 | $4K | Hold |
450
| – | – | ﹤0.01% | 3639 |
|
|
2022
Q1 | $3K | Sell |
450
-150
| -25% | -$1K | ﹤0.01% | 3733 |
|
|
2021
Q4 | $8K | Sell |
600
-98
| -14% | -$1.31K | ﹤0.01% | 3484 |
|
|
2021
Q3 | $12K | Buy |
698
+98
| +16% | +$1.69K | ﹤0.01% | 3341 |
|
|
2021
Q2 | $17K | Hold |
600
| – | – | ﹤0.01% | 3205 |
|
|
2021
Q1 | $24K | Buy |
+600
| New | +$24K | ﹤0.01% | 2936 |
|